
Yahoo · 28 de jul de 2026
In the most recent trading session, Pfizer (PFE) closed at $25.25, indicating a +2.35% shift from the previous trading day.
Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Últimos 252 días · 17/07/25 — 28/07/26
+27.12%
Precio de cierre en pesos argentinos. Fuente: data912.
Precio
$ 10.030
Var. %
0%
Precio PFE
US$ 25,29
Teórico (precio / ratio)
PFE ÷ 4
US$ 6,32
Cotización
US$ 6,54
vs teórico
+3,44%
Cotización MEP implícita
$ 1.533,64
Cotización
US$ 6,10
vs teórico
-3,52%
Cotización Cable implícita
$ 1.644,26
Sí, existe el CEDEAR de PFE (Pfizer Inc.) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es PFE.
El ticker del CEDEAR de Pfizer Inc. en Argentina es PFE. La acción subyacente cotiza en NYSE con el símbolo PFE.
El CEDEAR PFE tiene un ratio de 4:1. Eso significa que 4 CEDEARs equivalen a 1 acción de PFE.
El CEDEAR PFE cotiza hoy a $ 10.030 en pesos argentinos, con una variación diaria de 0%.
La acción subyacente PFE (Pfizer Inc.) cotiza a US$ 25,29 en su mercado de origen (NYSE).
El precio teórico del CEDEAR PFE se calcula dividiendo el precio de PFE por el ratio (4). Hoy resulta en US$ 6,32.
En BYMA podés operar PFE en pesos, PFED en dólar MEP y PFEC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR PFE en pesos argentinos, con datos de data912.

Yahoo · 28 de jul de 2026
In the most recent trading session, Pfizer (PFE) closed at $25.25, indicating a +2.35% shift from the previous trading day.

Yahoo · 28 de jul de 2026
Johnson & Johnson stock's oncology engine and its steady guidance raises were on the record quarters before the price moved.

Yahoo · 28 de jul de 2026
One of the market's strongest health care performers barely moves with the index you already own, and that gap is the whole point.

Yahoo · 28 de jul de 2026
AbbVie's two newest drugs are growing so fast they've rewritten the company's entire story, and Wall Street may not have fully priced in what happens when the J…

Yahoo · 28 de jul de 2026
Eli Lilly's expanding oncology and newer medicine portfolio is set to play a pivotal role in its Q2 earnings alongside its blockbuster GLP-1 franchise.

Yahoo · 28 de jul de 2026
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectation…

Yahoo · 28 de jul de 2026
As the biopharmaceutical industry prepares to convene for Cambridge Healthtech Institute's 18th Annual Bioprocessing Summit, taking place August 10-13, 2026, in…

Yahoo · 28 de jul de 2026
DENVER, July 28, 2026--As artificial intelligence reshapes cybersecurity, risk management, and enterprise leadership, organizations are looking for practical st…
Noticias vía Finnhub